Volunteers scrambled to procure drugs they knew little about and couldn’t pronounce: Baricitinib, Tocilizumab. Lists were compiled of hospitals with available beds, chemists who had Remdesivir and plasma, hospitals admitting patients in the ICU. Everyone I knew was glued to their phones. The ...